COGNEX CORP (CGNX)
About COGNEX CORP
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $994.4M
- Net income
- $114.4M
- Total assets
- $2.0B
- Market cap
- $10.1B
- Gross margin
- 66.9%
- Operating margin
- 16.3%
- Net margin
- 11.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $994.4M
- Cost of revenue
- $329.0M
- Gross profit
- $665.4M
- Operating expenses
- $502.8M
- Operating income
- $162.6M
- Income tax
- $68.4M
- Net income
- $114.4M
- EPS (basic)
- $0.68
- EPS (diluted)
- $0.68
Balance sheet
- Total assets
- $2.0B
- Current assets
- $697.2M
- Total liabilities
- $524.7M
- Current liabilities
- $183.6M
- Shareholders’ equity
- $1.5B
Cash flow
- Operating cash flow
- $245.5M
- Investing cash flow
- $28.0M
- Financing cash flow
- -$206.7M
- Net cash flow
- $76.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $10.1B
- P/E ratio
- 91.2
- EPS (diluted)
- $0.68
- Dividend yield
- 0.55%
- Shares outstanding
- 163.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 20, 1989
Cognex Corp (CGNX) Stock Price
- Profitable — net income of $114.4M in FY2025.
- Revenue declined 4% from FY2021 to FY2025.
- Gross margin of 66.9%, net margin 11.5%.
- Trading 14% below its 52-week high.
- Pays a dividend yielding about 0.55% annually.
- Valued at a price-to-earnings (P/E) ratio of 91.2.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review COGNEX CORP.
Write a review
News about COGNEX CORP
News & sentiment via Polygon.io
Cognex Corp: frequently asked questions
Is Cognex Corp an American company?
Yes — Cognex Corp is an American company headquartered in Natick, Massachusetts. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Cognex Corp headquartered?
Cognex Corp is headquartered in Natick, Massachusetts, United States.
Is Cognex Corp publicly traded?
Yes — Cognex Corp is a publicly traded company. Its stock trades under the ticker symbol CGNX on the NASDAQ.
What does Cognex Corp do?
Cognex Corp is an American Medical Devices company in the Health & Beauty sector.
When was Cognex Corp founded?
Cognex Corp was founded in 1981.
